66
Views
2
CrossRef citations to date
0
Altmetric
Original Research

TRAP1 Shows Clinical Significance in the Early Diagnosis of Small Cell Lung Cancer

ORCID Icon, , , , , , , , , & ORCID Icon show all
Pages 2507-2514 | Published online: 14 Jun 2021

References

  • Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85(1). doi:10.5334/aogh.2419
  • Tsoukalas N, Aravantinou-Fatorou E, Baxevanos P, et al. Advanced small cell lung cancer (SCLC): new challenges and new expectations. Ann Transl Med. 2018;6(8):145. doi:10.21037/atm.2018.03.31
  • Agorreta J, Hu J, Liu D, et al. TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC. Mol Cancer Res. 2014;12(5):660–669. doi:10.1158/1541-7786.MCR-13-0481
  • Restall IJ, Lorimer IAJ. Induction of premature senescence by Hsp90 inhibition in small cell lung cancer. PLoS One. 2010;5(6):e11076. doi:10.1371/journal.pone.0011076
  • Lee JH, Kang KW, Kim JE, et al. Differential expression of heat shock protein 90 isoforms in small cell lung cancer. Int J Clin Exp Pathol. 2015;8:9487.
  • Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors. J Thorac Oncol. 2015;10(9):1243–1260. doi:10.1097/JTO.0000000000000630
  • Caballero Vázquez A, Garcia Flores P, Romero Ortiz A, García Del Moral R, Alcázar Navarrete B. Small cell lung cancer: recent changes in clinical presentation and prognosis. Clin Respir J. 2020;14(3):222–227. doi:10.1111/crj.13119
  • Hoter A, El-Sabban M, Naim H. The HSP90 family: structure, regulation, function, and implications in health and disease. Int J Mol Sci. 2018;19(9):2560. doi:10.3390/ijms19092560
  • Basit F, van Oppen LM, Schöckel L, et al. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells. Cell Death Dis. 2017;8(3):e2716–e2716. doi:10.1038/cddis.2017.133
  • Faienza F, Rizza S, Giglio P, Filomeni G. TRAP1: a metabolic hub linking aging pathophysiology to mitochondrial S-Nitrosylation. Front Physiol. 2020;11. doi:10.3389/fphys.2020.00340
  • Rasola A, Neckers L, Picard D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 2014;24(8):455–463. doi:10.1016/j.tcb.2014.03.005
  • Matassa D, Agliarulo I, Avolio R, Landriscina M, Esposito F. TRAP1 regulation of cancer metabolism: dual role as oncogene or tumor suppressor. Genes-Basel. 2018;9(4):195. doi:10.3390/genes9040195
  • Kuchitsu Y, Nagashio R, Igawa S, et al. TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma. Biomed Res. 2020;41(1):53–65. doi:10.2220/biomedres.41.53
  • Tan L, Zhang Y, Jiang Y, et al. The clinical significance of anti-mitotic spindle apparatus antibody (MSA) and anti-centromere antibody (ACA) detected in patients with small cell lung cancer (SCLC). Am J Clin Exp Immunol. 2017;6(2):21–26.
  • Wu Y, Tan L, Chen J, et al. MAD2 combined with Mitotic Spindle Apparatus (MSA) and Anticentromere Antibody (ACA) for diagnosis of Small Cell Lung Cancer (SCLC). Med Sci Monit. 2018;24:7541–7547. doi:10.12659/MSM.909772
  • Pinsky P, Gierada DS. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans. Lung Cancer. 2020;139:179–184. doi:10.1016/j.lungcan.2019.11.017